US BROKER MOVES: HCC upgraded at UBS; FSLR downgraded at BMO

The recent upgrades and downgrades from major brokerages indicate a mixed outlook for stocks, reflecting shifting analyst sentiments.

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

South African Interest Rate Decision 6.75% vs. Exp. 6.75% (Prev. 6.75%); two members favoured a cut of 25bps, while four preferred a hold.

Mastercard (MA) Q4 2025 (USD): Adj. EPS 4.76 (exp. 4.24), Revenue 8.8bln (exp. 8.78bln)

US BROKER MOVES: HCC upgraded at UBS; FSLR downgraded at BMO

ArcelorMittal (MT NA) announces that it has been served by the Extraordinary Commissioners of Acciaierie d'Italia, with a writ of summons to appear before the Court of Milan

[CALENDAR ADDITION] US President Trump to make an announcement at 21:30GMT / 16:30EST

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

UPGRADES

  • BBB Foods (TBBB) Upgraded to Overweight at Morgan Stanley; PT USD 46
  • Brown & Brown (BRO) Upgraded to Market Perform at KBW; PT USD 73
  • Cencora (COR) Upgraded to Overweight at Morgan Stanley; PT USD 400
  • Fortinet (FTNT) Upgraded to Buy at Rosenblatt Securities Inc; PT USD 100
  • General Motors (GM) Upgraded to Buy at DZ Bank; PT USD 98
  • Korro Bio, Inc. (KRRO) Upgraded to Buy at HC Wainwright; PT USD 20
  • Korro Bio, Inc. (KRRO) Upgraded to Buy at Chardan Capital Markets; PT USD 15
  • Korro Bio, Inc. (KRRO) Upgraded to Overweight at Piper Sandler; PT USD 30
  • Lam Research (LRCX) Upgraded to Buy at Summit Insights
  • Littelfuse (LFUS) Upgraded to Buy at Benchmark; PT USD 360
  • NVR (NVR) Upgraded to Neutral at Zelman; PT USD 7,675
  • Warrior Met (HCC) Upgraded to Buy at UBS; PT USD 108
  • Werner Enterprises (WERN) Upgraded to Neutral at Baird; PT USD 34
  • Zillow (ZG) Upgraded to Equal-Weight at Barclays; PT USD 72

DOWNGRADES

  • AGNC Investment (AGNC) Downgraded to Market Perform at KBW; PT USD 12
  • Amcor (AMCR) Downgraded to Equal-Weight at Morgan Stanley; PT USD 46
  • CalciMedica (CALC) Downgraded to Neutral at HC Wainwright
  • First Solar (FSLR) Downgraded to Market Perform at BMO; PT USD 263
  • Omega Healthcare (OHI) Downgraded to Equal-Weight at Wells Fargo; PT USD 45
  • PagSeguro (PAGS) Downgraded to Neutral at Grupo Santander; PT USD 14
  • Prosperity Banc (PB) Downgraded to Neutral at Piper Sandler; PT USD 74
  • Stellar Bancorp (STEL) Downgraded to Market Perform at Raymond James
  • StoneCo (STNE) Downgraded to Neutral at Grupo Santander; PT USD 21

INITIATIONS

  • Adlai Nortye (ANL) ADRs Initiated at New Buy at Lucid Capital Markets; PT USD 11
  • American Healthcare REIT (AHR) Initiated at New Outperform at BMO; PT USD 55
  • Amprius Technologies (AMPX) Initiated at New Buy at Needham; PT USD 20
  • Bicara Therapeutics (BCAX) Initiated at New Market Outperform at Citizens
  • LightPath Tech (LPTH) Initiated at New Buy at Canaccord; PT USD 15
  • Sharplink Gaming (SBET) Initiated at New Buy at Canaccord; PT USD 16
  • TPG (TPG) Initiated at New Overweight at Barclays; PT USD 78
Context

HCC's upgrade by UBS to 'Buy' suggests confidence in its growth potential, which could attract interest, while First Solar's downgrade at BMO signals concerns that could pressure its stock. Overall, these changes highlight the importance of keeping an eye on individual stock narratives as they may diverge from broader market trends.

Related headlines

The whole workspace, free to try.

Try it free